Clinical Microbiology Market: Introduction
- Clinical microbiology can be defined as a branch of medical science that is concerned with the prevention, diagnosis, and treatment of infectious diseases. It is concerned with various applications of microbes causing infectious diseases, including fungi, parasites, viruses, and bacteria.
- It includes a range of testing methodologies that significantly rely on culture-based methods and phenotypic methods for identification of culture organisms. Furthermore, clinical microbiology plays a major role in the diagnosis and management of diverse patients, including patients suffering from lower respiratory tract infections.
Key Drivers and Restraints of Global Clinical Microbiology Market
- Increase in prevalence of infectious diseases, globally, fuels the clinical microbiology market. According to WHO’s annual estimates, globally, there are over 300-500 million cases of malaria, over 300 cases of sexually transmitted diseases, over 15 million cases of tuberculosis, and over 4 million cases of cholera.
- Significant increase in the number of newer microorganisms causing diseases boosts investments on research & development activities focused on the development of diagnostic tests, thereby propelling the clinical microbiology market
- Technological advancements in disease diagnostics coupled with the emergence of a range of molecular diagnostics techniques aid in early detection and effective treatment of pathogen borne diseases. Growing adoption of advanced diagnostic techniques, including next generation sequencing (NGS), real-time PCR, and mass spectrometry coupled with PCR further aid in the effective identification and characterization of various pathogens.
- Lack of trained professionals and a lack of effective training programs, specifically in regions where the burden of infectious diseases is higher, is estimated to hamper the clinical microbiology market. However, increasing automation and replacement of manually operated conventional platforms might substitute for the lack of trained professionals.
North America to Lead Global Clinical Microbiology Market
- In terms of region, the global clinical microbiology market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global clinical microbiology market in 2019, owing to strong presence of leading market players, increasing investments on research & development, significant product launches, and growing prevalence of infectious diseases in the region
- Europe followed North America in terms of share of the global clinical microbiology market in 2019. The market in Asia Pacific is projected to expand at a rapid pace, followed by Latin America and Middle East & Africa. Rise in focus of governments of countries in Asia on enhancing healthcare facilities, increase in focus of market players on Asia Pacific to leverage growth opportunities, and an increase in the patient pool boost the clinical microbiology market in Asia Pacific.
Key Players Operating in Global Clinical Microbiology Market
Major market players are focused on expanding their presence in the global clinical microbiology market primarily by adopting inorganic growth strategies. Leading players operating in the global clinical microbiology market are:
- Danaher Corporation
- Abbott Laboratories
- Roche Diagnostics
- Agilent Technologies
- Thermo Fisher Scientific
- Becton Dickinson & Company
- Merck KGaA
- Bio-Rad Laboratories
Global Clinical Microbiology Market: Research Scope
Global Clinical Microbiology Market, by Product
- Laboratory Instruments
- Autoclave Sterilizers
- Blood Culture Systems
- Gram Stainers
- Microbial Analyzer
- Mass spectrometers
- General reagents
- Pathogen specific
Global Clinical Microbiology Market, by Indication
- Respiratory Diseases
- Sexually transmitted diseases
- Urinary Tract infections
- Periodontal diseases
Global Clinical Microbiology Market, by End-user
- Diagnostic Laboratories